Claim/exemption information - Registry number 3659151
List of suggested corrective measures
Disclose inhalation, ingestion, skin contact, and eye contact as likely routes of exposure.
Disclose the HMIRA registry number and correct date of decision granting the exemption, and clearly link which ingredients are part of the subject of the claim for exemption under the HMIRA.
Disclose the colour.
Disclose the correct and complete LD50 values (see appendix 4).
Disclose the initial Canadian supplier(s).
Disclose the percent of unknown acute oral toxicity, and percent of unknown acute inhalation toxicity.
Disclose the precautionary statements for each of the product hazard classification categories or subcategories (see appendix 1).
Disclose the product oral, dermal, and inhalation (dust/mist) acute toxicity estimates (ATEs) of 1065 mg/kg (37% unknown), 2970 mg/kg (37% unknown), and 1.42 mg/L (47% unknown), respectively.
Disclose the relevant first-aid measures (see appendix 2).
Disclose the relevant precautions for safe handling (see appendix 3).
Disclose the restrictions on use.
Disclose the supplemental label element in the case of a hazardous product classified as an acute toxicant.
Remove the disclosure of misleading information regarding “Flammability (solid, gas)”.